These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 18207668

  • 1. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
    King CR, Spiotto MT.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):23-7. PubMed ID: 18207668
    [Abstract] [Full Text] [Related]

  • 2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 3. Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
    King CR, Presti JC, Brooks JD, Gill H, Spiotto MT.
    Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1472-7. PubMed ID: 17935902
    [Abstract] [Full Text] [Related]

  • 4. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR, Presti JC, Gill H, Brooks J, Hancock SL.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):341-7. PubMed ID: 15145146
    [Abstract] [Full Text] [Related]

  • 5. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C, Montorsi F, Fiorino C, Alongi F, Bolognesi A, Da Pozzo LF, Guazzoni G, Freschi M, Roscigno M, Scattoni V, Rigatti P, Di Muzio N.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):966-74. PubMed ID: 19619960
    [Abstract] [Full Text] [Related]

  • 6. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA.
    Cancer; 2002 Dec 01; 95(11):2302-7. PubMed ID: 12436435
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
    Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):112-8. PubMed ID: 22300563
    [Abstract] [Full Text] [Related]

  • 9. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, De Meerleer G.
    Eur Urol; 2011 Oct 01; 60(4):842-9. PubMed ID: 21514039
    [Abstract] [Full Text] [Related]

  • 10. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis.
    Bernard JR, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, Schild SE, Pisansky TM.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):735-40. PubMed ID: 19464818
    [Abstract] [Full Text] [Related]

  • 11. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586
    [Abstract] [Full Text] [Related]

  • 12. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
    Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC.
    J Urol; 2006 Sep 01; 176(3):985-90. PubMed ID: 16890677
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.
    Choo R, Danjoux C, Gardner S, Morton G, Szumacher E, Loblaw DA, Cheung P, Pearse M.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):983-9. PubMed ID: 19409726
    [Abstract] [Full Text] [Related]

  • 14. Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?
    Khuntia D, Reddy CA, Mahadevan A, Klein EA, Kupelian PA.
    Cancer; 2004 Mar 15; 100(6):1283-92. PubMed ID: 15022298
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T, Lohm G, Bottke D, Höcht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1009-16. PubMed ID: 18963539
    [Abstract] [Full Text] [Related]

  • 17. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):415-9. PubMed ID: 15667961
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy.
    Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J.
    Int J Radiat Oncol Biol Phys; 2007 Apr 01; 67(5):1411-7. PubMed ID: 17275204
    [Abstract] [Full Text] [Related]

  • 20. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
    Pai HH, Eldridge B, Bishop D, Alexander A, Lesperance M, Blood P, Lim J, Ludgate C.
    Can J Urol; 2009 Apr 01; 16(2):4541-52. PubMed ID: 19364426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.